Selected new reviews and commentaries, 1 October 2009

1 October 2009

The expansion of newborn screening: is reproductive benefit an appropriate pursuit?
Bombard Y, Miller FA, Hayeems RZ et al. Nat Rev Genet. 2009 Oct;10(10):666-7. 

The ethics of egg manipulation.

Genomics shifts focus to rare disease.Check Hayden E. Nature. 2009 Sep 24;461(7263):458.

The ethical use of existing samples for genome research.Bathe OF, McGuire AL.Genet Med. 2009 Sep 10. [Epub ahead of print] 

Biobanks need pharma.

Genomic privacy and limits of individual detection in a pool.

Sankararaman S, Obozinski G, Jordan MI, Halperin E. Nat Genet. 2009 Sep;41(9):965-7.

Consent for biobank tissue in somatic-cell nuclear transfer.Jones DA, MacKellar C. Lancet. 2009 Sep 12;374(9693):861-3.

Alzheimer's disease beyond APOE.
 
Interferon-alfa, interferon- and hepatitis C.
 
Data's shameful neglect.

Huntington's disease: the case for genetic modifiers.
Gusella JF, Macdonald ME. Genome Med. 2009 Aug 21;1(8):80.

Cancer genomes - continuing progress.

Personalized medicine and inhibition of EGFR signaling in lung cancer.
Gazdar AF. N Engl J Med. 2009 Sep 3;361(10):1018-20.
 
Causes and consequences of microRNA dysregulation in cancer.

With new prenatal testing, will babies with Down syndrome slowly disappear?Skotko BG. Arch Dis Child. 2009 Jun 15.

The evolutionary consequences of erroneous protein synthesis.

Planning for translational research in genomics.
Hawkins N, de Vries J, Boddington P, Kaye J, Heeney C. Genome Med. 2009 Sep 11;1(9):87.

Can our understanding of epigenetics assist with primary prevention of congenital defects?Martínez-Frías ML. J Med Genet. 2009 Sep 15. [Epub ahead of print]

Epistasis and its implications for personal genetics.Moore JH, Williams SM. Am J Hum Genet. 2009 Sep;85(3):309-20.

More from us

Genomics and policy news